Patents by Inventor Simon Teague

Simon Teague has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted indoles
    Patent number: 8093278
    Abstract: The present invention relates to substituted indoles of formula (I), useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Grant
    Filed: April 28, 2010
    Date of Patent: January 10, 2012
    Assignee: AstraZeneca AB
    Inventors: Timothy Birkinshaw, Roger Bonnert, Tony Cook, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • Novel Substituted Indoles
    Publication number: 20100210685
    Abstract: The present invention relates to substituted indoles of formula (I), useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Application
    Filed: April 28, 2010
    Publication date: August 19, 2010
    Inventors: Timothy Birkinshaw, Roger Bonnert, Tony Cook, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • Indole-3-Sulphur Derivatives
    Publication number: 20100197756
    Abstract: The present invention relates to substituted indoles useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Application
    Filed: April 12, 2010
    Publication date: August 5, 2010
    Inventors: Roger Bonnert, Mark Dickinson, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • Substituted indoles
    Patent number: 7754735
    Abstract: The present invention relates to substituted indoles of formula (I), useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Grant
    Filed: May 27, 2003
    Date of Patent: July 13, 2010
    Assignee: AstraZeneca AB
    Inventors: Timothy Birkinshaw, Roger Bonnert, Tony Cook, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • Indole-3-sulphur derivatives
    Patent number: 7723373
    Abstract: The present invention relates to substituted indoles useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Grant
    Filed: July 15, 2003
    Date of Patent: May 25, 2010
    Assignee: AstraZeneca AB
    Inventors: Roger Bonnert, Mark Dickinson, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • 1-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders
    Publication number: 20080027092
    Abstract: The present invention relates to substituted indoles of formula (I) useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Application
    Filed: November 24, 2004
    Publication date: January 31, 2008
    Inventors: Roger Victor Bonnert, Rukhsana Tasneem Mohammed, Simon Teague
  • Substituted indoles
    Patent number: 7166607
    Abstract: The present invention relates to substituted indoles of formula (I) useful as pharmaceutical compounds for treating respiratory disorders
    Type: Grant
    Filed: May 27, 2003
    Date of Patent: January 23, 2007
    Assignee: AstraZeneca AB
    Inventors: Roger Bonnert, Stephen Brough, Tony Cook, Mark Dickinson, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • Indole-3-sulphur derivaties
    Publication number: 20060111426
    Abstract: The present invention relates to substituted indoles useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Application
    Filed: July 15, 2003
    Publication date: May 25, 2006
    Inventors: Roger Bonnert, Mark Dickinson, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • Novel substituted indoles
    Publication number: 20050222201
    Abstract: The present invention relates to substituted indoles of formula (I), useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Application
    Filed: May 27, 2003
    Publication date: October 6, 2005
    Inventors: Timothy Birkinshaw, Roger Bonnert, Tony Cook, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • Novel substituted indoles
    Publication number: 20050165055
    Abstract: The present invention relates to substituted indoles of formula (I) useful as pharmaceutical compounds for treating respiratory disorders.
    Type: Application
    Filed: May 27, 2003
    Publication date: July 28, 2005
    Inventors: Roger Bonnert, Stephen Brough, Tony Cook, Mark Dickinson, Rukhsana Rasul, Hitesh Sanganee, Simon Teague
  • Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
    Publication number: 20050165033
    Abstract: The invention relates to 1-(quinazolinfyl)- and 1-(quinolin-4-yl)-indole-3-acetic acid derivatives of the general formula and their use in the treatment of respiratory diseases; such as asthma, rhinitis and chronic obstructive pulmonary disease (COPD); and other diseases mediated by prostaglandin D2 (PGD2).
    Type: Application
    Filed: February 4, 2003
    Publication date: July 28, 2005
    Inventors: Andrew Baxter, John Steele, Simon Teague
  • Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
    Publication number: 20050101612
    Abstract: The invention relates to N-substituted indole-3-acetic acid derivatives of the general formula in which R1 is optionally substituted benzothiazolyl, pyrimidin-4-yl, imidazol-2-yl, oxazol-2-yl or thiazol-2-yl, R2 is hydrogen, halogen, C1-6alkyl or C1-6alkoxy and R3 is hydrogen or C1-6alkyl (see further details in the description), and their use in the treatment of respiratory diseases such as asthma, rhinitis and chronic obstructive pulmanory disease (COPD), and other diseases mediated by prostaglandin D2(PGD2).
    Type: Application
    Filed: February 4, 2003
    Publication date: May 12, 2005
    Inventors: Andrew Baxter, John Steele, Simon Teague
  • Novel compounds
    Publication number: 20050075334
    Abstract: The present invention relates to new compounds of formula (I) wherein R1, R2, R3, R4, R5 and A are defined as in formula (I), a process for their preparation and new intermediate prepared therein, pharmaceutical compositions containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the treatment of c-Jun N-terminal kinase (JNK) mediated conditions in mammals, particularly Alzheimer's Disease.
    Type: Application
    Filed: December 18, 2002
    Publication date: April 7, 2005
    Inventors: Sarah King, Simon Teague, Yafeng Xue, Britt-Marie Swahn